You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imfinzi

Showing 26 - 50 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

Non Small Cell Lung Cancer Trial in Lexington (Durvalumab, Copanlisib)

Recruiting
  • Non Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center
Feb 21, 2022

Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

Not yet recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Ablative Radiation
  • +3 more
  • (no location specified)
Mar 11, 2022

Nonsmall Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab)

Not yet recruiting
  • Nonsmall Cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center
Apr 29, 2022

Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Completed
  • Non-small Cell Lung Cancer
  • Calgary, Alberta, Canada
  • +4 more
Jun 28, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Saint Louis (Durvalumab, Acalabrutinib)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2022

Larynx, Lip, Oral Cancer Trial in Chapel Hill, Charleston (Durvalumab, Intensity Modulated Radiotherapy Treatments)

Active, not recruiting
  • Larynx
  • +3 more
  • Durvalumab
  • Intensity Modulated Radiotherapy Treatments
  • Chapel Hill, North Carolina
  • +1 more
May 26, 2022

NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • Stereotactic body radiotherapy
  • +2 more
  • (no location specified)
Jul 5, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
Jan 12, 2023

Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Stanford, California
    Stanford University
Oct 27, 2022

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Houston, Texas
  • +7 more
Feb 1, 2023

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

Recruiting
  • Glioma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 29, 2021

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Durvalumab
  • Radiation Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Stanford, California
    Stanford University
Mar 25, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

Lung Cancer, NSCLC, PD-L1 Gene Mutation Trial in Detroit (Durvalumab, Carboplatin, Pemetrexed)

Withdrawn
  • Lung Cancer
  • +3 more
  • Detroit, Michigan
    Henry Ford Health System
Feb 15, 2022

Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Stage III Non-small-cell Lung Cancer
  • Durvalumab
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 18, 2023

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Colorectal Cancer Stage IV, No Evidence of Disease State Trial in Genova (Durvalumab Injection for intravenous use 500 mg vial

Recruiting
  • Colorectal Cancer Stage IV
  • No Evidence of Disease State
  • Durvalumab Injection for intravenous use 500 mg vial solution for infusion
  • Regorafenib 30 mg capsules
  • Genova, Liguria, Italy
    IRCCS Ospedale Policlinico San Martino
May 16, 2022